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OBJECTIVES: To determine whether hearing loss is asso-
ciated with incident physician-diagnosed dementia in a
representative sample.
DESIGN: Retrospective cohort study.
SETTING: English Longitudinal Study of Ageing.
PARTICIPANTS: Adults aged 50 and older.
MEASUREMENTS: Cross-sectional associations between
self-reported (n = 7,865) and objective hearing measures
(n = 6,902) and dementia were examined using multino-
mial-logistic regression. The longitudinal association
between self-reported hearing at Wave 2 (2004/05) and
cumulative physician-diagnosed dementia up to Wave 7
(2014/15) was modelled using Cox proportional hazards
regression.
RESULTS: After adjustment for potential confounders, in
cross-sectional analysis, participants who had self-reported
or objective moderate and poor hearing were more likely
to have a dementia diagnosis than those with normal hear-
ing (self-reported: odds ratio OR = 1.6, 95% CI = 1.1–2.4
moderate hearing; OR = 2.6, 95% CI = 1.7–3.9 poor
hearing, objective: OR = 1.6, 95% CI = 1.0–2.8 moderate
hearing; OR = 4.4, 95% CI = 1.9–9.9 poor hearing). Lon-
gitudinally, the hazard of developing dementia was 1.4
(95% CI = 1.0–1.9) times as high in individuals who
reported moderate hearing and 1.6 (95% CI = 1.1–2.0)
times as high in those who reported poor hearing.
CONCLUSION: Older adults with hearing loss are at
greater risk of dementia than those with normal hearing.
These findings are consistent with the rationale that correc-
tion of hearing loss could help delay the onset of dementia,
or that hearing loss itself could serve as a risk indicator for
cognitive decline. J Am Geriatr Soc 65:2074–2081, 2017.
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The global estimate of the number of individuals livingwith dementia was 46.8 million in 2015, with approx-
imately 800,000 residing in the United Kingdom and
676,000 living in England.1 The estimated economic cost
of dementia in the United Kingdom is approximately £23
billion per annum, which is predicted to triple by 2040.1
In addition, the overwhelming social impact on individuals
with dementia and their families has contributed to
dementia becoming a public health priority.2–4
A number of modifiable risk factors for dementia have
been identified, including social interactions, physical activ-
ity, and type 2 diabetes mellitus.5 There is also evidence that
hearing loss could be a risk factor.6–8 As with dementia, the
risk of hearing loss increases with age. It was estimated that
more than 3 million adults aged 50 and older in the United
Kingdom had hearing loss in 2011, despite the fact that
reporting or diagnosing these conditions is challenging.9
The Health Survey for England found that only 26% of
individuals with moderate or severe objective hearing loss
had previously had a formal hearing test and that 60% of
individuals aged 55 and older who could have better hearing
with a hearing aid had never used one.10
Previous longitudinal epidemiological studies con-
ducted in the United States and Wales have provided evi-
dence that hearing loss is independently associated with
dementia,6,7,11,12 but these studies have focused on adults
aged 70 and older,11 included only men in their analysis,6
not included the use of hearing aids as a confounding
factor,6,12 had small sample sizes,7 or had no objective hear-
ing measure.12 The current study was therefore designed to
investigate whether subjective and objective measures of
hearing loss were independently associated with dementia
using cross-sectional and longitudinal analysis in a represen-
tative sample of adults aged 50 and older in England.
METHODS
Study Population
Data were used from a cohort of men and women aged 50
and older from the English Longitudinal Study of Ageing
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(ELSA),13 a panel study set up in 2002 with a parallel
study design to the Health and Retirement Study in the
United States.13 Face-to-face interviews and tests have been
conducted at 2-year intervals (Waves 1–7, 2002/03–2014/
15) to obtain information on socioeconomic circum-
stances, physical and mental health, and cognitive function
in adults as they progress into retirement.
Outcome Measures
A three-way assessment protocol was used to define
dementia as described previously.14 The primary criterion
was a physician diagnosis of dementia as reported by par-
ticipants or informants in Waves 2 to 7.14 Caregivers then
completed an adapted short-form Informant Questionnaire
on Cognitive Decline in the Elderly (IQCODE) for individ-
uals who were not able to respond themselves.14 Care-
givers were asked to compare the present functional
performance of the participant 2 years before, instead of
the 10-year interval in the standard measure.15 Consistent
with previous work, those with a score greater than 3.5
were defined as having dementia because the IQCODE has
high specificity (0.84) and sensitivity (0.82) at this cut-
off.14,16 Individuals receiving prescriptions for anti-
cholinesterase inhibitors, N-methyl-D-aspartate receptor
antagonists, or other relevant medications (galantamine,
rivastigmine, memantine, donepezil, or tacrine) were also
determined to have dementia.17,18 Many people with
dementia do not have a formal diagnosis.19 These analyses
should therefore be regarded as a measure of physician-
diagnosed dementia and not complete incident dementia.
Exposure Measures
Self-Reported Hearing
Participants were asked to rate their hearing from 1 (excel-
lent) to 5 (poor) in Waves 1 to 7.20 Individuals with hearing
aids were asked to rate their hearing based on when they
used their hearing aid.20 Self-reported hearing was used at
Wave 2 (2004/05, longitudinal analysis) and Wave 7 (2014/
15, cross-sectional analysis). There were originally five self-
reported hearing groups (excellent, very good, good, fair,
poor); fair and poor (poor) and excellent and very good
(normal) were combined to create three categories for anal-
ysis (normal, moderate difficulties, poor hearing).10,20
Objective Hearing Test
A hearing screening device (HearCheck Screener, Siemens,
Germany) was used to obtain objective hearing scores for
participants at Wave 7 (2014/15). This device has been vali-
dated and was used in the Health Survey for England in
2014.10 Hearing loss was measured according to decibel
hearing level (dbHL), which is the level in decibels needed
for a person to hear a sound at a certain frequency at least
half the time.10 The test involves presentation of six increas-
ing volumes of sounds at different frequency levels; partici-
pants indicate which tones they can hear.10,21 Both ears
were tested in a quiet environment, and hearing aids were
removed before the test.10 The test was not conducted with
people who had a cochlear implant or ear infection.10
Individuals were classified as having hearing loss if they
could hear only mid-frequency sounds at 20 dbHL and
high-frequency sounds at 35 dbHL. Responses were origi-
nally categorized into four groups (good hearing, moderate
loss, severe loss, profound loss). For the current study, the
lower two (severe and profound loss) were combined,
resulting in three groups (normal, moderate difficulties,
poor hearing).
Other Independent Variables
Age was classified into four categories (50–59, 60–69, 60–79,
≥80). Economic status was defined using quintiles of non-pen-
sion wealth (1 = low, 5 = high) as calculated by the Institute
for Fiscal Studies.13 Participants’ highest educational qualifica-
tions were divided into three groups (no formal qualification,
intermediate education, higher education). Ethnicity was
divided into white and non-white. Smoking was categorized
into three groups (never smoker, ex-smoker, current smoker).
The following variables were binary: use of hearing aid, dia-
betes mellitus, hypertension, history of stroke.22
Statistical Analysis
The sociodemographic and clinical risk profiles were
summarized according to self-reported (Waves 2–7, 2004/
05–2014/15) and objective (Wave 7, 2014/15) hearing cate-
gories. Chi-square tests were performed to ascertain whether
there were significant differences in the distribution of
sociodemographic and clinical categories between hearing
groups. For the cross-sectional analyses of self-reported and
objective hearing impairment, odds ratios and 95% confi-
dence intervals of diagnosed dementia at Wave 7 (2014/15)
were calculated, with normal hearing as the reference group.
Separate analyses were conducted on self-reported and
objective hearing impairment. On the basis of the existing
literature, it was decided a priori that age, sex, ethnicity,
wealth, education, and hearing aid use were possible
confounders.7,11,23 The following cardiovascular risk factors
were also adjusted for: smoking status, diabetes mellitus,
hypertension, and stroke. A forward stepwise approach was
used, and likelihood ratio tests and the Akaike Information
Criterion were used to select the model of best fit.24,25
Cox proportional hazards regression was used to model
the association between self-reported hearing (Wave 2,
2004/05) and cumulative diagnosed dementia (July 2005 to
June 2015). The Health Survey for England has calculated
cross-sectional and longitudinal weighting to adjust for non-
response bias.22,26 Cross-sectional weights were derived for
participants responding at each wave, and longitudinal
weights were calculated using logistic regression models to
estimate probability of non-response using household- and
individual-level data collected in the previous wave.22 Sig-
nificant differences were found between responders and
non-responders with regard to age, sex, region, highest edu-
cation qualification, marital status, and self-reported general
health.22 Both weights were used to adjust for non-response
bias in the cross-sectional (Wave 7, 2014/15) and longitudi-
nal (Waves 2–7, 2004/05–2014/15) analyses.22
Individuals who had been diagnosed with dementia in
Wave 2 (2004/05) were excluded. Time to dementia was
measured in years from the beginning of Wave 2 (2004/05).
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Date of dementia diagnosis was used if known; if not
known, the midpoint date between waves of data collection
was used. Individuals who were known to have died or left
the study were censored. Mortality data for ELSA were
available up to February 2013. If an individual dropped out
of the study between waves, the last interview date was used
for the censor date. The Schoenfeld residual test was used to
test the proportional hazards assumption of the models.27
Sensitivity Analysis
To examine whether the self-report and objective measures
had independent effects on risk of dementia, both measures
were included in one model. Individuals who wore hearing
aids were excluded from the sensitivity analysis because the
self-report measure was based on hearing aid use, and the
objective measure was not. Finally, to avoid misinterpreting
the results of communication difficulties as a sign of cogni-
tive impairment, a sensitivity analysis that omitted individu-
als who fit the IQCODE cut-off criteria but did not have a
physician diagnosis of dementia were included.
All data were analyzed using STATA version 14
(STATA Corp LP, College Station, TX).
RESULTS
Cross-Sectional Analyses
Ninety-five percent (7,865/8,253) of participants in Wave 7
rated their hearing, with 23.1% (n = 1,771) reporting poor
and 34.7% (n = 2,669) moderate hearing difficulties. Self-
reported hearing difficulties were associated with older age,
male sex, lower wealth and education, hearing aid use, his-
tory of stroke, and diabetes or hypertension (Table 1).
Approximately 84% (6,902/8,253) of the participants
had a hearing screening test in Wave 7 (Table S1). Fewer
individuals were categorized into the poor objective hearing
group (5%) than the poor self-reported hearing group
(23%), but a similar proportion (34% vs 35%) were in the
moderate hearing group. Objective hearing difficulties were
associated with a similar set of demographic and clinical
factors as were self-reported hearing difficulties (Table S1).
Dementia was associated with worse self-reported and
objective hearing (Table 2). After adjustment for con-
founders, participants in the moderate and poor self-
reported hearing groups were 1.6 (95% CI = 1.05–2.37)
and 2.6 (95% CI = 1.74–3.93) times more likely to have a
dementia diagnosis as those with normal hearing. Similarly,
those in the moderate and poor hearing groups for the hear-
ing screening test were 1.6 (95% CI = 0.93–2.84) and 4.4
(95% CI = 1.94–9.91) times as likely to have a diagnosis of
dementia. Older age, hypertension, and previous stroke
were risk factors for dementia diagnosis, whereas greater
wealth, intermediate and higher education, and using a
hearing aid seemed to have protective effects (Table 2).
Longitudinal Analyses
Of the 8,780 core members in Wave 2, 22% (n = 1,933)
reported poor hearing, and 31.6% (n = 2,774) moderate
Table 1. Participant Characteristics According to Self-Reported Hearing Ability (Wave 7, 2014/15)
Characteristic
Total Cohort from
Wave 7, n = 7,685
Self-Reported Hearing
P-Value*
Poor, n = 1,771
(23.1%)
Moderate Difficulties,
n = 2,669 (34.7%)
Normal,
n = 3,242 (42.2%)
n (%)
Dementia 193 (2.5) 86 (4.9) 67 (2.5) 40 (1.2) <.001
Age
50–59 937 (12.2) 131 (7.42) 287 (10.8) 519 (16.0) <.001
60–69 3,139 (40.9) 571 (32.2) 1,054 (39.5) 1512 (46.6)
70–79 2,414 (31.4) 610 (34.4) 888 (33.3) 914 (28.2)
≥80 1,196 (15.5) 459 (25.9) 440 (16.5) 297 (9.2)
Female 4,302 (55.9) 786 (43.4) 1,479 (55.4) 2,054 (63.4) <.001
Wealth quartile
1 (low) 1,292 (16.8) 377 (21.3) 448 (16.8) 466 (14.4) <.001
2 1,384 (18.0) 368 (20.8) 479 (17.9) 535 (16.5)
3 1,632 (20.8) 378 (21.3) 566 (21.2) 688 (21.2)
4 1,694 (22.4) 339 (19.1) 595 (22.3) 760 (23.4)
5 (high) 1,683 (22.0) 309 (17.5) 581 (21.8) 793 (24.5)
Non-white 261 (3.4) 51 (2.9) 105 (3.9) 105 (3.2) .52
Education
No qualifications 1,838 (23.9) 557 (31.5) 654 (24.5) 626 (19.3) <.001
Intermediate 3,100 (40.3) 658 (37.2) 1,055 (39.5) 1,386 (42.8)
Higher 2,747 (35.8) 556 (31.4) 960 (35.9) 1,230 (37.9)
Hearing aid 1,041 (13.6) 557 (31.4) 354 (13.3) 130 (4.1) <.001
Diabetes mellitus 1,070 (13.9) 329 (18.6) 352 (13.2) 389 (12.0) <.001
Hypertension 3,836 (49.9) 1,006 (56.8) 1,362 (51.1) 1,006 (56.8) <.001
Stroke 457 (5.9) 157 (8.9) 169 (6.3) 131 (4.1) <.001
Current smoker 810 (10.5) 176 (9.9) 270 (10.1) 364 (11.2) .17
Mean age 70.2  9.5
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hearing difficulties. Self-reported hearing difficulty was
associated with older age, male sex, lower wealth and edu-
cation, hearing aid use, hypertension, and history of stroke
(Table 3).
There were 269 incident cases of diagnosed dementia
between Wave 2 and the end of Wave 7 (June 2015). Dur-
ing the mean follow-up of 11 years, individuals in the
moderate (hazard ratio (HR) = 1.39, 95% CI = 1.01–
1.92) and poor (HR = 1.57, 95% CI = 1.12–2.02) hearing
groups were at greater risk of developing dementia than
the normal hearing group. Older age and diabetes mellitus
also emerged as significant independent risk factors
(Table 4).
Sensitivity Analysis
There was fair agreement between the objective and self-
reported hearing measures (j = 0.262, 95% CI = 0.257–
0.269). The association between objective hearing and
physician-diagnosed dementia remained significant for the
poor hearing group when including self-reported hearing
in the model. In contrast, the association between self-
reported hearing difficulties weakened and became
non-significant. The associations did not change when
individuals who used a hearing aid were excluded. When
individuals with an IQCODE greater than 3.5 only were
omitted from the model, the odds ratios were smaller but
remained significant.
DISCUSSION
The study found that moderate and poor objective and
self-reported hearing were cross-sectionally associated with
physician-diagnosed dementia in a representative sample of
English older adults (mean age 70  9.5). Longitudinal
analysis over an 11-year period showed that the incidence
was 39% higher in individuals with moderate self-reported
hearing and 57% higher in those with poor self-reported
hearing than in those with normal hearing after adjusting
for multiple covariates.
Comparison with Other Studies
The Health and Retirement Study, which has a profile
similar to that of ELSA, also examined self-reported hear-
ing and dementia cross-sectionally and found that 44% of
participants who reported fair to poor hearing had proba-
ble dementia.28 The Health and Retirement Study analysis
focused on the last 2 years of life rather than a longer per-
iod, and their definition of probable dementia was based
on an algorithmic analysis of cognitive function rather
than physician diagnosis.28,29
The current study built on previous longitudinal stud-
ies conducted in the United States and Wales that found
that individuals with moderate and severe hearing loss
were at greater risk of developing dementia.6,7,12,22 Six
hundred thirty-nine adults aged 65 and older from the Bal-
timore Longitudinal Study of Aging were prospectively
analysed over 11.9 years.7 It was found not only that
objective hearing loss was independently associated with
incident dementia, but also that risk increased log-linearly
with severity of hearing loss (mild hearing loss:
HR = 1.89, 95% CI = 1.00–3.58; moderate hearing
loss: HR = 3.00, 95% CI = 1.43–6.30; severe hearing loss,
HR = 4.94, 95% CI = 1.09–22.40).7 The CI for the severe
hearing loss category was large, probably because of the
small number of cases in that category (n = 6). Another
study tracked older adults (N = 1,889, aged 70–79) from
the Health, Aging and Body Composition Study for
9 years and found that individuals with moderate to severe
objective hearing impairment were more likely to develop
dementia than those whose hearing was normal
(HR = 1.55, 95% CI = 1.10–2.19). Older men from the
Caerphilly Study in Wales (N = 1,057) were followed for
17 years, and an association was found between objective
auditory threshold and dementia (OR = 2.67, 95%
CI = 1.38–5.18). Unlike the other previous studies, they
included only men in their analysis.6 Finally, the Cache
County Study on Memory, Health, and Aging in the Uni-
ted States (N = 4,545) followed older adults (≥65) for
13 years and also found that hearing loss was an
Table 2. Odds of Dementia According to Cross-Sec-
tional Self-Reported Hearing and Objective Hearing
Test (Wave 7, 2014/15)
Hearing Test
Model 1 (Unadjusted) Model 2 (Adjusted)
Odds Ratio (95% Confidence Interval) P-Value
Self-reported hearing (reference normal)
Moderate 2.06 (1.39–3.06) <.001 1.58 (1.05–2.37) .03
Poor 4.08 (2.79–5.97) <.001 2.62 (1.74–3.93) <.001
Age (reference 50–59)
60–69 1.65 (0.57–4.79) .36 1.70 (0.58–4.97) .33
70–79 5.34 (1.93–14.8) .001 4.95 (1.77–13.8) .002
≥80 24.6 (9.03–66.9) <.001 21.2 (7.67–58.7) <.001
Female 1.12 (0.84–1.50) .43 0.93 (0.66–1.26) .66
Wealth quartile (reference 1)
2 0.69 (0.47–1.02) .07 0.77 (0.51–1.17) .22
3 0.56 (0.37–0.83) .001 0.71 (0.46–1.08) .11
4 0.35 (0.22–0.54) .001 0.53 (0.32–0.87) .01
5 0.22 (0.13–0.38) .001 0.43 (0.24–0.77) .005
Education (reference no qualifications)
Intermediate 0.33 (0.23–0.46) <.001 0.54 (0.38–0.78) .001
Higher 0.29 (0.20–0.42) <.001 0.71 (0.47–1.08) .11
Hearing aid 0.65 (0.40–1.05) .08 0.24 (0.14–0.39) .04
Hypertension 2.59 (1.89–3.56) <.001 1.56 (1.11–2.17) .01
Stroke 7.38 (5.33–10.2) <.001 4.04 (2.83–5.76) <.001
Objective hearing (reference normal)
Moderate 2.41 (1.44–4.03) .001 1.62 (0.93–2.84) .09
Poor 7.54 (4.01–14.2) <.001 4.39 (1.94–9.91) <.001
Age (reference 50–59)
60–69 1.06 (0.35–3.22) .92 1.16 (0.38–3.56) .79
70–79 2.69 (0.94–7.69) .07 2.39 (0.81–7.07) .11
≥80 7.02 (2.47–19.9) <.001 4.55 (1.49–13.1) .008
Female 1.13 (0.71–1.79) .59 1.04 (0.64–1.68) .64
Wealth quartile (reference 1)
2 0.37 (0.18–0.75) .06 0.46 (0.23–0.96) .23
3 0.51 (0.28–0.94) .03 0.64 (0.34–1.20) .34
4 0.32 (0.16–0.63) .001 0.41 (0.19–0.85) .19
5 0.21 (0.09–0.47) <.001 0.33 (0.14–0.78) .14
Education (reference no qualifications)
Intermediate 0.38 (0.21–0.66) .001 0.63 (0.35–1.10) .10
Higher 0.43 (0.25–0.73) .002 0.99 (0.53–1.86) .99
Hearing aid 0.68 (0.42–1.05) .08 0.24 (0.24–0.99) .046
Hypertension 1.71 (1.07–2.72) .02 1.06 (0.65–1.72) .82
Stroke 4.32 (2.39–7.79) <.001 2.48 (1.34–4.61) .004
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independent risk factor for developing dementia,12
although identification of hearing loss was questionable
because it was based on interviewer ratings that were not
a mandatory part of the assessment protocol.
The previous studies of objective hearing loss used a
pure tone audiometry test, whereas the current study used
self-reported hearing measures in the longitudinal
analyses.6,7,11 Nevertheless, a significant positive associa-
tion was found between the self-reported and objective test
measure in Wave 7. In addition, pure tone audiometry and
the hearing screening test used are comparable, with simi-
lar sensitivities (89% and 94%) and specificities (87% and
82%).30 When self-reported and objective measures were
entered into the same models competitively, associations
between objective hearing loss and dementia were more
robust.
Strengths and Limitations
A unique strength of using ELSA is that it involves a large
national sample of resident English men and women aged
50 and older. The dataset includes repeated measures of
chronic conditions, so it was possible to capture cumula-
tive physician-diagnosed dementia cases and analyze time
to dementia diagnosis. The dataset also had measures of
self-reported and objective hearing measures at Wave 7
that could be compared in the presence of other potential
covariate measures.
There are also several limitations to these analyses.
First, there were fewer individuals with dementia in this
study than in population estimates,31,32 primarily because
dementia was identified on the basis of physician
diagnosis; it is thought that only approximately half of
people living with dementia have a formal diagnosis.33
Individuals with dementia based on an IQCODE score
greater than 3.5 were therefore also included.15,29,34 Attri-
tion bias is also relevant,27 although this was allowed for
by using probability weights for non-responders.22,26
Second, only self-reported hearing measures were
available in ELSA for longitudinal analysis; objective mea-
sures would be desirable. Comparison of subjective and
objective measures of hearing loss was also challenging,
because only self-reported hearing was based on hearing
aid use, although the two measures had a significant posi-
tive association. In addition, use of a hearing aid was
included as a confounder in the analysis.
Finally, categorizations of subjective and objective
hearing measures do not match directly because they are
based on rather different criteria.
Possible Causal Mechanisms
Although longitudinal associations between self-reported
hearing loss and future dementia were identified, it is not
certain that the associations are causal. Major confounders
such as age, education, and cardiovascular risk factors
were adjusted for statistically, but there could be residual
confounding by unmeasured variables. In addition, demen-
tia develops over many years, so pathological processes
may have been initiated even before baseline measures of
hearing. Nevertheless, there are three possible mechanisms
by which hearing loss could cause dementia; cognitive bur-
den, changes in brain structure and function, and social
isolation. First, cognitive burden or the “effortfulness
Table 3. Participant Characteristics According to Self-Reported Hearing Ability (Wave 2–2004/05)
Characteristic
Total Cohort from
Wave 2, n = 8,780
Self-Reported Hearing
P-Value
Poor, n = 1,933
(22.0%)
Moderate Difficulties,
n = 2,774 (31.6%)
Normal, n = 4,073
(46.4%)
N (%)
Age
50–59 2,597 (29.6) 371 (19.2) 772 (27.8) 1,454 (35.7) <.001
60–69 2,874 (32.7) 537 (27.8) 941 (33.9) 1,396 (34.3)
70–79 2,188 (24.9) 599 (31.0) 694 (25.0) 895 (22.0)
≥80 1,121 (12.8) 426 (22.0) 367 (13.2) 328 (8.10)
Female 4,831 (55.0) 848 (43.9 1,468 (52.9) 2,515 (61.7) <.001
Wealth quartile
1 (low) 1,583 (18.3) 445 (23.0) 475 (17.1) 663 (16.3) <.001
2 1,724 (19.9) 459 (23.7) 523 (18.9) 742 (18.2)
3 1,741 (20.1) 372 (19.2) 557 (20.1) 812 (19.9)
4 1,773 (20.5) 334 (17.3) 579 (20.9) 860 (21.1)
5 (high) 1,840 (21.2) 303 (15.7) 605 (21.8) 932 (22.9)
Non-white 206 (2.2) 52 2.7) 55 (2.0) 99 (2.4) .26
Education
No qualifications 3,487 (39.6) 912 (47.2) 1,080 (38.9) 1,476 (36.2) <.001
Intermediate 3,219 (36.6) 647 (33.5) 997 (35.9) 1,565 (38.4)
Higher 2,100 (23.9) 371 (19.2) 693 (25.0) 1,029 (25.3)
Hearing aid 561 (6.5) 385 (19.9) 143 (5.2) 41 (1.0) <.001
Diabetes mellitus 248 (2.8) 72 (3.7) 76 (2.7) 100 (2.5) .02
Hypertension 1,079 (12.3) 273 (14.1) 362 (13.0) 444 (10.9) .001
Stroke 142 (1.6) 55 (2.8) 43 (1.6) 44 (1.1) <.001
Current smoker 1,329 (15.1) 304 (15.7) 412 (14.9) 613 (15.1) .69
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hypothesis” has been demonstrated in older adults (66–
81).34,35 Although the numbers of older adults with hear-
ing impairment were small (n = 12, n = 24), findings sug-
gested that older individuals with hearing loss had poorer
recall and secondary task performance.35,36 Sound signals
become more distorted in individuals with hearing loss,
especially in the high-frequency range, leading to greater
effort in perceiving sound.35,36 The extra cognitive load on
individuals with hearing loss could be at the expense of
encoding and processing speech into memory.35,36
Second, lack of sensory input and difficulty processing
may lead to changes in brain structure and function.6–8 Evi-
dence from cross-sectional studies suggests that hearing
impairment is associated with a reduction in the cortical vol-
ume of the primary auditory cortex in the temporal lobe and
variable white matter fibers.37 Neuroimaging data from par-
ticipants enrolled in the neuroimaging substudy of the Balti-
more Longitudinal Study of Aging strengthened the
evidence, showing that hearing impairment in older adults
was associated with a greater rate of decline in whole brain
volume, particularly in the right temporal lobe, which is
responsible for processing of speech.38 The majority of indi-
viduals (n = 126, aged 58–86) with hearing impairment
were in the mild hearing category.
Finally, lack of interaction and intellectual stimulation
has been associated with dementia in prospective
studies.38,39 Social gatherings may be more challenging for
individuals with hearing impairment because they use
more cognitive resources to process speech, which may
increase withdrawal from social activities. Swedish older
adults were examined prospectively (n = 776, aged ≥75),
and the results suggested that individuals who participated
less in social, mental, or physical activity had a greater risk
of developing dementia.39 Furthermore, cross-sectional and
prospective studies have shown an independent association
between hearing loss and social isolation.40 Social isolation
may therefore be a mediator on the causal pathway of
dementia through which hearing impairment acts.40
Clinical Implications
Is hearing loss an indicator of early stages of dementia and
a preventable risk factor, or is dementia an indicator of
hearing loss? There are opposing arguments regarding the
direction of the association between hearing and dementia,
but either pathway could have major public health
implications.
In the United Kingdom, approximately 4 million peo-
ple with hearing impairment delay seeking medical help.41
Unlike eye tests, individuals seem to be reluctant to have
hearing tests, possibly because of the stigma associated
with hearing loss, which could be reduced by using a
screening program.41 One study of hearing screening for
older adults showed a positive benefit to cost ratio.42 Con-
sequently, the Department of Health has developed an
action plan on hearing that includes awareness, early
detection, and treatment for hearing loss.43
Hearing aids could help with treatment of hearing loss
and possibly decrease social isolation, although they need to
be acceptable and effective. The quality of hearing aids
seems to have improved, and 70% of older adults reported
being fairly satisfied with their hearing aids in the Health
Survey for England.10 Individuals who were tested at a
younger age benefitted more from their hearing aids because
they had more time to adapt.41 Combined with detection
and treatment, hearing loss could also be an early indicator
for cognitive decline and dementia.
CONCLUSION
This study supports previous literature that has found that
older adults with hearing loss have a higher rate of devel-
oping dementia. It also found that hearing aid use had a
protective effect in cross-sectional analysis. The findings
suggest that treatment of hearing loss with hearing aids
could help delay the onset of dementia. The public health
implications are substantial because more than 3 million
U.K. adults aged 50 and older have hearing loss. Further
studies are needed to confirm the possible biological and
social mechanisms involved, and a large prospective study
is needed to examine treatment of hearing loss.
Table 4. Hazard Ratio of Self-Reported Hearing at
Wave 2 (2004/05) and Cumulative Dementia (Waves 3
–7, 2006/07–2014/15)
Characteristic
No
Dementia,
n = 8,382
Dementia,
n = 269 Hazard Ratio (95%
Confidence
Interval) P-Valuen (%)
Self-reported hearing
Normal 3,921 (46.8) 85 (31.6) 1
Moderate 2,645 (31.6) 90 (33.5) 1.39 (1.01–1.92) .04
Poor 1,816 (21.7) 94 (34.9) 1.57 (1.12–2.02) .009
Age
50–59 2,520 (30.1) 19 (7.1) 1
60–69 2,795 (33.4) 45 (16.7) 2.06 (1.19–3.66) .01
70–79 2,062 (24.6) 101 (37.6) 6.44 (3.86–10.7) <.001
≥80 1,005 (12.0) 108 (40.2) 18.3 (10.6–31.5) <.001
Sex
Male 3,791 (45.2) 103 (38.3) 1
Female 4,591 (54.8) 172 (63.9) 1.09 (0.84–1.41) .52
Wealth quartile
1 1,525 (18.2) 55 (20.5) 1
2 1,650 (19.7) 69 (25.7) 1.34 (0.97–2.11) .07
3 1,688 (20.2) 53 (19.7) 1.06 (0.75–1.71) .57
4 1,725 (20.6) 48 (17.8) 1.08 (0.71–1.71) .66
5 1,794 (21.4) 44 (16.4) 1.04 (0.67–1.87) .65
Education
No
qualifications
3,295 (39.3) 142 (52.8) 1
Intermediate 3,082 (36.7) 79 (29.4) 0.78 (0.56–1.03) .07
Higher 2,005 (23.9) 48 (17.8) 0.79 (0.53–1.16) .22
Hearing aid
No 7,850 (93.7) 238 (88.5) 1
Yes 532 (6.3) 31 (11.5) 0.99 (0.61–1.42) .74
Hypertension
No 7,354 (87.7) 228 (84.8) 1
Yes 1,028 (12.3) 41 (15.2) 1.01 (0.68–1.52) .94
Stroke
No 8,249 (98.4) 262 (97.4) 1
Yes 133 (1.6) 7 (2.6) 0.82 (0.33–1.57) .41
Diabetes mellitus
No 8,150 (97.3) 253 (94.1) 1
Yes 230 (2.7) 16 (5.9) 2.39 (1.35–4.57) .003
JAGS SEPTEMBER 2017–VOL. 65, NO. 9 HEARING IMPAIRMENT AND DEMENTIA IN OLDER ADULTS 2079
ACKNOWLEDGMENTS
The National Research and Ethics Committee granted Eth-
ical approval for all the ELSA waves (http://www.nres.
npsa.nhs.uk/).
Financial Disclosure: This work was supported by the
Promoting Independence in Dementia study, which was
funded by the UK Economic and Social Research Council
and National Institute for Health Research (Grant ES/
L001802/1). ELSA is funded by the National Institute on
Ageing (Grant RO1AG7644) and by a consortium of U.K.
government departments coordinated by the ESRC. The
data are lodged with the U.K. Data Archive. Andrew Steptoe
is supported by the British Heart Foundation. The authors
would like to thanks participants of the ELSA study.
Conflict of Interest: None.
Author Contributions: Study concept and design: HD
and AS. Data analysis: HD, AH. Writing the manuscript:
HD. Editing subsequent drafts: AS, MO, DC, AH.
Sponsor’s Role: The funders of the study had no role
in the study design, data collection, data analysis, data
interpretation, writing of the report, decision to publish,
or preparation of the manuscript.
REFERENCES
1. Alzheimer’s Society. Dementia 2014 Report Statistics [on-line]. Available at
https://www.alzheimers.org.uk/statistics Accessed August 23, 2016.
2. Department of Health. Living Well with Dementia. A National Dementia
Strategy [on-line]. Available at https://www.gov.uk/government/uploads/sys
tem/uploads/attachment_data/file/168220/dh_094051.pdf Accessed Septem-
ber 19, 2016.
3. Department of Health. 2010 to 2015 Government Policy: Dementia [on-
line]. Available at https://www.gov.uk/government/publications/2010-to-
2015-government-policy-dementia/2010-to-2015-government-policy-deme
ntia Accessed June 20, 2016.
4. Public Health England. Our Priorities for 2013/14 [on-line]. Public Health
England: London; 2013 [on-line]. Available at https://www.gov.uk/govern
ment/uploads/system/uploads/attachment_data/file/192676/Our_priorities_
final.pdf Accessed July 7, 2016.
5. Baumgart M, Snyder HM, Carillo MC et al. Summary of the evidence on
modifiable risk factors for cognitive decline and dementia: A population-
based perspective. Alzheimers Dement 2015;11:718–726.
6. Gallacher J, Ilubaera V, Ben-Shlomo Y et al. Auditory threshold, phono-
logic demand, and incident dementia. Neurology 2012;79:1583–1590.
7. Lin FR, Metter EJ, O’Brien RJ et al. Hearing loss and incident dementia.
Arch Neurol 2011;68:214.
8. Lin FR, Albert M. Hearing loss and dementia—who’s listening? Aging
Ment Health 2014;18:671–673.
9. Akeroyd MA, Foreman K, Holman JA. Estimates of the number of adults
in England, Wales, and Scotland with a hearing loss. Int J Audiol
2014;53:60–61.
10. Scholes S, Mindell J. Health Survey for England: Chapter 4: Hearing [on-
line]. The Health and Social Care Information Centre; 2014 [on-line].
Available at http://www.hscic.gov.uk/catalogue/PUB19295/HSE2014-ch4-
hear.pdf Accessed May 20, 2016.
11. Deal JA, Betz J, Yaffe K et al. Hearing impairment and incident dementia
and cognitive decline in older adults: The Health ABC Study. J Gerontol A
Biol Sci Med Sci 2017;72:703–709.
12. Gurgel RK, Ward PD, Schwartz S et al. Relationship of hearing loss and
dementia: A prospective, population-based study. Otol Neurotol
2014;35:775–781.
13. Steptoe A, Breeze E, Banks J et al. Cohort profile: The English Longitudi-
nal Study of Ageing. Int J Epidemiol 2013;42:1640–1648.
14. Khondoker M, Rafnsson S, Morris M et al. Positive and negative experiences
of social support and risk of dementia in later life: An investigation using the
English Longitudinal Study of Ageing. J Alzheimers Dis 2017;58:99–108.
15. Jorm AF. A short form of the Informant Questionnaire on Cognitive
Decline in the Elderly (IQCODE): Development and validation. Psychol
Med 1994;24:145–153.
16. Quinn TJ, Fearon P, Noel-Storr AH et al. Informant Questionnaire on
Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia
within community dwelling populations. Cochrane Database Syst Rev
2014;10:CD010079.
17. BMJ Group. British National Formulary, vol. 72. London: Pharmacy Press,
2016.
18. National Institute for Health and Care. Donepezil, Galantamine,
Rivastigmine and Memantine for the Treatment of Alzheimer’s Disease.
London: NICE; 2016. Report No.: TA217 [on-line]. Available at https://
www.nice.org.uk/guidance/ta217/chapter/1-guidance Accessed September
27, 2016.
19. Brayne C, Davis D. Making Alzheimer’s and dementia research fit for pop-
ulations. Lancet 2012;380:1441–1443.
20. Marmot M, Banks J, Blundell R et al. Health, Wealth and Lifestyles of the
Older Population in England: ELSA 2002, vol. 2. London: Institute for Fis-
cal Studies, 2003.
21. Siemens Audiologische Technik GmbH. Hear Check Screener User Guide.
PUBLICIS; 2007 [on-line]. Available at http://www.connevans.info/image/c
onnevans/38shearcheck.pdf Accessed September 2, 2016.
22. Banks J, Batty GD, Nazroo J et al. The Dynamics of Ageing: Evidence
From the English Longitudinal Study of Ageing 2002–15 (Wave 7), Vol. 7.
London: Institute for Fiscal Studies, 2016.
23. Deal JA, Sharrett AR, Albert MS et al. Hearing impairment and cognitive
decline: A pilot study conducted within the Atherosclerosis Risk in Com-
munities Neurocognitive Study. Am J Epidemiol 2015;181:680–690.
24. Akaike H. A new look at the statistical model identification. IEEE Trans
Autom Control 1974;19:716–723.
25. Zucchini W. An introduction to model selection. J Math Psychol
2000;44:41–61.
26. Mansournia MA, Altman DG. Inverse probability weighting. BMJ
2016;352:i189.
27. Cleves M, Gutierrez RG, Gould W et al. An Introduction to Survival Anal-
ysis Using Stata, 3rd Ed. Texas: STATA, 2016.
28. Smith AK, Ritchie CS, Miao Y et al. Self-reported hearing in the last two
years of life among older adults. J Am Geriatr Soc 2016;64:1486–1491.
29. Crimmins EM, Kim JK, Langa KM et al. Assessment of cognition using
surveys and neuropsychological assessment: The Health and Retirement
Study and the Aging, Demographics, and Memory Study. J Gerontol B Psy-
chol Sci Soc Sci 2011;66B(Suppl 1):i162–i171.
30. Bamford J, Fortnum H, Bristow K et al. Current practice, accuracy, effec-
tiveness and cost-effectiveness of the school entry hearing screen. Health
Technol Assess 2007;11:1–168, iii–iv.
31. Matthews FE, Stephan BCM, Robinson L et al. A two decade dementia
incidence comparison from the Cognitive Function and Ageing Studies I
and II. Nat Commun 2016;7:11398.
32. Matthews FE, Arthur A, Barnes LE et al. A two-decade comparison of
prevalence of dementia in individuals aged 65 years and older from three
geographical areas of England: Results of the Cognitive Function and Age-
ing Study I and II. Lancet 2013;382:1405–1412.
33. Alzhemier’s Society. Dementia Diagnosis Rates [on-line]. Available at
https://www.alzheimers.org.uk/site/scripts/documents_info.php?docume
ntID=2165 Accessed August 22, 2016.
34. Harrison JK, Fearon P, Noel-Storr AH et al. Informant Questionnaire on
Cognitive Decline in the Elderly (IQCODE) for the diagnosis of dementia
within a secondary care setting (Review). Cochrane Database Syst Rev
2015;10:CD010772.
35. Tun PA, McCoy S, Wingfield A. Aging, hearing acuity, and the attentional
costs of effortful listening. Psychol Aging 2009;24:761–766.
36. McCoy S, Tun PA, Cox LC et al. Hearing loss and perceptual effort:
Downstream effects on older adults’ memory for speech. Q J Exp Psychol
2005;58:22–33.
37. Chang Y, Lee SH, Lee YJ et al. Auditory neural pathway evaluation on
sensorineural hearing loss using diffusion tensor imaging. NeuroReport
2004;6:1699–1703.
38. Lin FR, Ferrucci L, Goh JO et al. Association of hearing impairment with
brain volume changes in older adults. NeuroImage 2014;90:84–92.
39. Wang H-X, Karp A, Winblad B et al. Late-life engagement in social and
leisure activities is associated with a decreased risk of dementia: A longitu-
dinal study from the Kungsholmen Project. Am J Epidemiol
2002;155:1081–1087.
40. Mick P, Kawachi I, Lin FR. The association between hearing loss and
social isolation in older adults. Otolaryngol Head Neck Surg
2014;150:378–384.
41. Davis A, Smilth P. Adult hearing screening: Health policy issues-what hap-
pens next? Am J Audiol 2013;22:167–170.
42. Cost Benefit Analysis of Hearing Screening for Older People. Final Report
for RNID. London: London, Economics, 2010.
2080 DAVIES ET AL. SEPTEMBER 2017–VOL. 65, NO. 9 JAGS
43. Action on Hearing Loss. Statistics [on-line]. Available at https://
www.actiononhearingloss.org.uk/your-hearing/about-deafness-and-hearing-
loss/statistics.aspx Accessed June 14, 2016.
SUPPORTING INFORMATION
Additional Supporting Information may be found in the
online version of this article:
Table S1. Descriptive statistics of dementia and objec-
tive hearing test
Please note: Wiley-Blackwell is not responsible for the
content, accuracy, errors, or functionality of any support-
ing materials supplied by the authors. Any queries (other
than missing material) should be directed to the corre-
sponding author for the article.
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